LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA
Animals · 21.09.2023 · 13 (18) · 2987
DOI: 10.3390/ani13182987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 21.09.2023. Verfasst von Hiroki Sato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Medical Center, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Akiyama Life Science Foundation.
Abstract (Originalsprache)
Splenic hemangiosarcoma is one of the most common malignant tumors in dogs, and early diagnosis is of great importance for achieving a good prognosis. DNA methylation plays an important role in cancer development. Long interspersed nuclear element 1 (LINE-1) is the most abundant repetitive element in the genome. LINE-1 hypomethylation has been shown to be related to carcinogenesis in humans, and it has been used as a novel cancer biomarker. This study aimed to evaluate the methylation status of LINE-1 in tumor tissue and circulating cell-free DNA and assess its clinical significance in canine splenic hemangiosarcoma. Genomic DNA was isolated from splenic masses of 13 dogs with hemangiosarcoma, 11 with other malignant tumors, and 15 with benign lesions. LINE-1 methylation was quantified using methylation-sensitive and -insensitive restriction enzyme digestion followed by real-time polymerase chain reaction. Additionally, blood samples were collected from eight patients to isolate cell-free DNA to determine LINE-1 methylation status changes during the treatment course. LINE-1 methylation in tumor samples was significantly lower in patients with hemangiosarcoma than in those with other malignant tumors and benign lesions. Non-significant but similar results were observed for the cell-free DNA samples. Our results demonstrate that LINE-1 methylation status is a potential biomarker for splenic hemangiosarcoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Veterinary Medical Center, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan.
- Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan.
- Department of Veterinary Science, Osaka Metropolitan University, Izumisano 545-8585, Japan.
- Department of Veterinary Clinical Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan.
- Department of Veterinary Associated Science, Okayama University of Science, Imabari 794-8555, Japan.
ORCID-Profile: Ken-Ichi Watanabe
Förderung
- Akiyama Life Science Foundation
Zitieren
APA
Sato, H., Watanabe, K. I., Kobayashi, Y., Tomihari, M., Uemura, A., & Tagawa, M. (2023). LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA. Animals, 13(18), 2987. https://doi.org/10.3390/ani13182987
Vancouver
Sato H, Watanabe KI, Kobayashi Y, Tomihari M, Uemura A, Tagawa M. LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA. Animals. 2023;13(18):2987. doi:10.3390/ani13182987
BibTeX
@article{Sato2023,
author = {Sato, Hiroki and Watanabe, Ken-Ichi and Kobayashi, Yoshiyasu and Tomihari, Mizuki and Uemura, Akiko and Tagawa, Michihito},
title = {LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA},
journal = {Animals},
year = {2023},
volume = {13},
number = {18},
pages = {2987},
doi = {10.3390/ani13182987}
}
EUVIMED